Bioscience Neutraceuticals, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was USD 440,919 compared to USD 1,488 a year ago. Net loss was USD 447,097 compared to USD 12,132 a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.05 a year ago.